Skip to main content
SpringerLink
Log in

Building a Stereotactic Radiosurgery Program for the Treatment of Prostate Cancer

  • Chapter
  • First Online:
Book cover Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications

Abstract

The focus of this chapter is to share the details of how to set up, promote, and successfully run a prostate stereotactic radiosurgery (SRS) program. Most importantly, this chapter describes what works well to promote a prostate SRS program and what does not work, so that time and money would not be wasted by those attempting to start a new prostate SRS program.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. King CR, Brooks JD, Gill H et al (2009) Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. Int J Radiat Oncol Biol Phys 73:1043–1048

    Article  PubMed  Google Scholar 

  2. Friedland JL, Freeman DE, Masterson-McGary ME et al (2009) Stereotactic body radiotherapy: an emerging treatment approach for localized prostate cancer. Technol Cancer Res Treat 8:387–392

    PubMed  CAS  Google Scholar 

  3. Katz AJ, Santoro M, Ashley R et al (2010) Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 10:1

    Article  PubMed  Google Scholar 

  4. Katz A (2010) CyberKnife radiosurgery for prostate cancer. Technol Cancer Res Treat 9(5):463–472

    PubMed  Google Scholar 

  5. Meier R. CyberKnife radiosurgery for organ-confined prostate cancer: homogenous dose distribution; 2008

    Google Scholar 

  6. Fuller DB. CyberKnife radiosurgery for low & intermediate risk prostate cancer: emulating HDR brachytherapy dosimetry; 2008

    Google Scholar 

  7. Fuller DB, Naitoh J, Lee C et al (2008) Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry com-parison with HDR brachytherapy and ­preliminary clinical observations. Int J Radiat Oncol Biol Phys 70:1588–1597

    Article  PubMed  Google Scholar 

  8. Fowler JF (2005) The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44:265–276

    Article  PubMed  Google Scholar 

  9. Martinez AA, Gustafson G, Gonzalez J et al (2002) Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53:316–327

    Article  PubMed  Google Scholar 

  10. Collins CD, Lloyd-Davies RW, Swan AV (1991) Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 3:127–132

    Article  CAS  Google Scholar 

  11. Wiegner EA, King CR (2010) Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial. Int J Radiat Oncol Biol Phys 78(2):442–448

    Article  PubMed  Google Scholar 

  12. Zelefsky MJ, Chan H, Hunt M et al (2006) Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176:1415–1419

    Article  PubMed  Google Scholar 

  13. Dubbelman YD, Dohle GR, Schroder FH (2006) Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol 50:711–718; discussion 718–720

    Article  PubMed  Google Scholar 

  14. Katz A, Santoro M, Ashley R et al (in press) Stereotactic body radiotherapy with and without external beam radiation therapy in treatment of organ confined prostate cancer. European Society for Therapeutic Radiology and Oncology Annual Meeting

    Google Scholar 

  15. Katz A, Santoro M, Ashley R et al (2010) Stereotactic body radiotherapy as boost for organ-confined prostate cancer. Technol Cancer Res Treat 9(6):575–582

    PubMed  Google Scholar 

  16. Pommier P, Chabaud S, Lagrange JL et al (2007) Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 25:5366–5373

    Article  PubMed  Google Scholar 

  17. Lawton CA, DeSilvio M, Lee WR et al (2007) Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98–05). Int J Radiat Oncol Biol Phys 67:39–47

    Article  PubMed  Google Scholar 

  18. Martinez AA, Demanes DJ, Galalae R et al (2005) Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 62:1322–1331

    Article  PubMed  Google Scholar 

  19. Bagrodia A, Diblasio CJ, Wake RW et al (2009) Adverse effects of androgen deprivation therapy in prostate cancer: current management issues. Indian J Urol 25:169–176

    Article  PubMed  Google Scholar 

  20. Sannazzari GL, Ragona R, Ruo Redda MG et al (2002) CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75:603–607

    PubMed  CAS  Google Scholar 

  21. King CR, Lo A, Kapp DS (2009) Testicular dose from prostate cyberknife: a cautionary note. Int J Radiat Oncol Biol Phys 73:636–637; author reply 637

    Article  PubMed  Google Scholar 

  22. Fuller DB (2009) Testicular dose from prostate cyberknife: a cautionary note in regard to King et al. Int J Radiat Oncol Biol Phys 73:637

    PubMed  Google Scholar 

  23. Athanassiou H, Antonadou D, Coliarakis N et al (2003) Protective effect of amifostine during fractionated radiotherapy in pa-tients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys 56:1154–1160

    Article  PubMed  CAS  Google Scholar 

  24. Simone NL, Menard C, Soule BP et al (2008) Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys 70:90–95

    Article  PubMed  CAS  Google Scholar 

  25. Toledano A, Chauveinc L, Flam T et al (2006) PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup. Brachytherapy 5:122–126

    Article  PubMed  Google Scholar 

  26. Pinkawa M, Piroth MD, Holy R et al (2010) Prostate-specific antigen kinetics following external-beam radiotherapy and tem-porary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer. Radiother Oncol 96(1):25–29

    Article  PubMed  Google Scholar 

  27. Zelefsky MJ, Shi W, Yamada Y et al (2009) Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortality. Int J Radiat Oncol Biol Phys 75:1350–1356

    Article  PubMed  Google Scholar 

  28. Stock RG, Klein TJ, Cesaretti JA et al (2009) Prognostic significance of 5-year PSA value for predicting prostate cancer recurrence after brachytherapy alone and combined with hormonal therapy and/or external beam radiotherapy. Int J Radiat Oncol Biol Phys 74:753–758

    Article  PubMed  Google Scholar 

  29. Freeman DE, Friedland JL, Masterson-McGary ME (2010) Stereotactic radiosurgery for low-intermediate risk prostate cancer: an emerging treatment approach. Am J Clin Oncol 33:208

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Flushing Radiation Oncology, Flushing, NY, USA

    Alan J. Katz M.D.

Authors
  1. Alan J. Katz M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dept. Urology, Center for Urologic Oncology &, University Hospitals Case Medical Center, Euclid Avenue 11100, Cleveland, 44106, Ohio, USA

    Lee E. Ponsky

  2. Radiosurgery Medical Group, Inc., San Diego Cyberknife Center, Ruffin Rd. 5395, San Diego, 92123, California, USA

    Donald B. Fuller

  3. Medical Director, Radiation Oncology, Swedish Cancer Institute at Northwest Ho, 1560 North 115th Street G16, Seattle, 98133, Washington, USA

    Robert M. Meier

  4. Director, Physics, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, 19111-2497, Pennsylvania, USA

    Charlie Ma

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Katz, A.J. (2012). Building a Stereotactic Radiosurgery Program for the Treatment of Prostate Cancer. In: Ponsky, L., Fuller, D., Meier, R., Ma, C. (eds) Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11495-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11495-3_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11494-6

  • Online ISBN: 978-3-642-11495-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation